Chris Werge retweeted
A breakthrough this week! Why do some develop Long COVID and others do not? It may have to do with one's ability to degrade glycosylated proteins!
Bleomycin, the Spike and Fibrosis: It's All About Localization and Clearance
Bleomycin is cleared by Bleomycin Hydrolase. The Spike's clearance may depend on an individual's ability to degrade glycosylated proteins!
Chris Werge retweeted
The 4th Long COVID International Conference just concluded in Nice, France.
These findings are from conference abstracts, many awaiting full publication, peer review, and independent replication.
Here’s the emerging pathobiology that caught my attention. 🧵
Chris Werge retweeted
A PERSONAL ADVICE:
🫀You suspect possible HEART issues after your COVID-19?
Make an appointment with your GP or cardiologist, and consider starting the conversation like this:
➡️"I've developed new symptoms such as [e.g., rapid heartbeat, dizziness, chest discomfort, or fatigue when standing], which began weeks/months after my COVID-19 infection. I'd like to discuss a targeted screening for my potential long-term cardiovascular complications, including myocarditis, arrhythmias, increased risk of heart attack/stroke, or postural orthostatic tachycardia syndrome (POTS), as clearly outlined in recent statements from the American Heart Association (AHA) and European Society of Cardiology (ESC), which recognise COVID-19 as an independent risk factor for these conditions, even after mild cases."
➡️These guidelines stress that even non-severe infections can lead to lasting CV risks, so early screening is key.
➡️‼️Better a negative result than a missed opportunity to catch issues early.
➡️To support your discussion, share these high-impact, peer-reviewed/official sources from 2024–2025 (print or digital, colleagues should value evidence from AHA & ESC): I made a "TOP-5" for you!
1. AHA Scientific Statement: Cardiac Arrhythmias and Autonomic Dysfunction Associated With COVID-19 (October 14, 2024).
-Reviews post-COVID arrhythmias and POTS, reports 1-year risk increases (e.g., atrial fibrillation hazard ratio 2.41) and urges long-term monitoring.
Link: ahajournals.org/doi/10.1161/…
2. AHA: COVID-19 May Increase Heart Attack and Stroke Risk for Years (October 9, 2024).
-Shows doubled risk of major cardiovascular events up to 3 years post-infection, comparable to having pre-existing heart disease.
Link: heart.org/en/news/2024/10/09…
3. AHA Scientific Statement: Exercise Intolerance and Response to Training in Patients With Postacute Sequelae of SARS-CoV-2 (Long COVID) (June 30, 2025).
-Details mechanisms of cardiac issues like POTS/myocarditis in Long COVID.
-Highlights 10–25% prevalence and need for multidisciplinary, tailored care.
Link: ahajournals.org/doi/10.1161/…
4. ESC Consensus Statement: Major New Report on Tackling the Profound and Lasting Impact of COVID-19 on Cardiovascular Health (September 18, 2025).
-Outlines acute and chronic effects (myocarditis, POTS/autonomic dysfunction in ~5% of cases) and vaccination’s protective role.
Link:
escardio.org/The-ESC/Press-O…
5. Nature Scientific Reports: Long-Term Cardiovascular Complications in COVID-19 Survivors (October 29, 2025).
-Demonstrates 16-fold higher major adverse cardiac events (MACE) risk at 1 year in ICU survivors,
-Aligns with AHA/ESC warnings on persistent inflammation and thrombosis.
Link:
nature.com/articles/s41598-0…
➡️Meanwhile… protect yourself and avoid SARS-CoV-2 reinfections as much as possible. #Mask
Stay safe and good luck at your appointment!
Chris Werge retweeted
Five years after catching COVID, 18-year-old Molly Foden is getting worse.
She now lives with ME/CFS, POTS and MCAS, has lost years of education and spent months in hospital.
Her Long COVID clinic closed in 2023. She deserves care, not closed doors.
bbc.com/news/articles/c8p3g3…
🎓 Tomorrow, Braeden Charlton defends his PhD on skeletal muscle abnormalities and post-exertional malaise in #LongCOVID and #MECFS.
His research has made an important contribution on understanding these diseases.
📅 12 Nov | 09:45 CET
🔴 Watch live:
vu.nl/nl/agenda/2026/promoti…
Chris Werge retweeted
#LongCOVID: Scientists detect hidden biological signals invisible to routine tests!
➡️ In a study of 96 people (48 with Long COVID and 48 recovered controls), ultra-sensitive proteomics detected 19 abnormally expressed proteins, despite routine tests often being normal.
➡️ The technology detected molecular signals at attomolar sensitivity—revealing subtle immune activation & neuroinflammation that conventional testing may miss. 1/
Chris Werge retweeted
My dear friend @JamesBlunt has asked me to buy his new record and I will, just as soon as he buys some Hawkstone for his pub.
Chris Werge retweeted
#LongCOVID: The brain may be working harder, even when cognitive tests appear normal!
➡️ A small study (34 patients with PCC and fatigue vs 37 controls) found:
Standard cognitive performance and immune markers remained largely within normal ranges.
➡️ MRI revealed subtle white-matter and myelin-related changes, with altered relationships between brain connectivity and cognitive performance. 1/
Chris Werge retweeted
It’s destroyed my life since 18. Long Covid, ME, MCAS all need research ASAP. Its killing people, probably will kill me. I’m not exaggerating its torture and like you’ve been dropped off in hell with constant symptoms and no medical help. We need change ASAP. #longcovid #ME #mcas
Six years ago, Beth Dobbin was competing at the highest level of international sport, representing Team GB at the Tokyo Olympics. Now, she is bedbound for up to 22 hours a day after being diagnosed with ME.
Commonly known as chronic fatigue syndrome, the condition has been described by Dobbin as “life-decimating”.
She has written a letter calling on the Prime Minister to meet with her and commit to more funding for research.
Dobbin’s fellow athletes Keely Hodgkinson, Tom Daley and Dina Asher-Smith have also signed the letter. #ME #illness #Olympics
Chris Werge retweeted
1/ 🚨 Could CAR-T therapy change the future of Long COVID and ME/CFS treatment?
Something remarkable is happening in autoimmune disease research.
Patients with severe, treatment-resistant autoimmune diseases are achieving prolonged remission after a single infusion of genetically modified T cells.
And a new study has revealed a particularly interesting connection between CAR-T therapy, Epstein–Barr virus (EBV), and autoreactive B cells.
I believe this could have important implications for certain post-infectious autoimmune subgroups.
Here’s what we know so far, and why I think this deserves much more attention.
Chris Werge retweeted
#LongCOVID & ME/CFS: Could the Brain’s
Waste-Clearance System Be Failing?
➡️ A new perspective proposes an intriguing connection between two debilitating post-infectious conditions—Long COVID and ME/CFS—and dysfunction of the brain’s glymphatic system, which helps clear metabolic waste from the brain.
➡️ The brain has its own waste-disposal network! Working alongside meningeal lymphatic drainage and cellular autophagy, it helps remove potentially toxic proteins and maintain brain health. 1/
Chris Werge retweeted
For those who think Long COVID is only the vax, something like Long COVID also happened to those with SARS-COV-1 in 2003.
With SARS-1, 40% to 60% of survivors had bad effects years out, and nearly 30% of infected healthcare workers still couldn't return to work.
With SARS-2, Long COVID hit 20% of early cases and 3% to 6% during Omicron, with about 15% of all versions averaged, are still being affected.
The data across both outbreaks makes it clear, that long-term disability is a predictable outcome for this virus family, not an anomaly.
So, please, if you are a family member/friend, or a medical professional, take it seriously.
BTW, I know people who it was the vaccine. So those disbelieving that it could be the vaccine, please do the same.
Help both!
Chris Werge retweeted
🔴 Ever wondered how Mast Cell Activation Syndrome (MCAS) might develop?
Could persistent infections and disrupted mucosal barriers contribute to mast cell activation?
🔬 Discover the mechanisms through scientific animations!
👇 Watch our new video!
Chris Werge retweeted
In the Netherlands, 16-year-old Charlotte has spent two years bedridden with Long COVID, unable to attend school or care for her horse.
She traveled to Italy for experimental immunoglobulin treatment, briefly improving before severe side effects.
ad.nl/westland/charlotte-16-…
Chris Werge retweeted
University of British Columbia researchers conducted a randomized trial of 160 Long COVID patients.
Low-dose naltrexone (LDN) did not significantly improve fatigue, pain, physical activity, or quality of life compared with placebo after 16 weeks.
medrxiv.org/content/10.64898…
Chris Werge retweeted
🧬 Your immune system is full of incredible secrets… and we’re just getting started!
💡 Follow @immunothings to discover more ImmunoThings!
Chris Werge retweeted
One of the most helpful things you can do for yourself as a patient is to begin to understand the biological mechanisms underlying the dysfunctions and symptoms you are experiencing.
Remember!! Treating symptoms and treating disease are not the same thing. Taking benzos or LDN or LDA or beta-blockers can help control symptoms of MECFS for some people but they cannot correct the dysfunction that is giving rise to the symptoms. For that we need an entirely different approach.
The first step to understanding how you can begin to take a bit more control of your condition is the right information. A little bit of knowledge can go a long way once you realize what is important to understand.
Bite size visual lessons are a great way of learning the basics. One of the biggest stumbling blocks I see in how patients approach treatment protocols is that they don't have any understanding of what is needed to start to address dysfunction.
In the end this means most people waste years following protocols with little real chance of moving the needle - just controlling symptoms is NOT enough.
We are not getting enough help from the medical community. Patients need clear options but we also need to understand the theory - not everything is right for everyone and complex protocols really are going to be essential. As much as we all wish for a major bullet - it is not going to be how people recovery from these types of conditions.
I think this is a great project and one that has the potential to really help patients. Excited to see where it goes. Amazing initiative @manruipa
🧬 Your immune system is full of incredible secrets… and we’re just getting started!
💡 Follow @immunothings to discover more ImmunoThings!
Chris Werge retweeted
»Vor fünf Jahren sprintete Beth Dobbin bei den Olympischen Spielen. Heute liegt sie aufgrund von ME/CFS über 22 Stunden am Tag im Bett. Selbst ein Gespräch kann ihre Symptome verschlimmern. Sportwissenschaftler Rob Wüst @RobWust erklärt, was diese Krankheit so verheerend macht.«
Gisteren verscheen er een stukje in Men's Health @MensHealthMag over ons onderzoek, en waarom ook profatleten long covid kunnen ontwikkelen (en hoe je het kunt onderscheiden van overtraining/gewone vermoeidheid):
menshealth.nl/nieuws/wat-is-…
#coverboy :)
Chris Werge retweeted
1/18. 🔴 Is it time to take antiviral treatments for Long COVID and ME/CFS more seriously?
I believe the growing body of scientific evidence is making this question increasingly difficult to ignore.
For years, viral persistence has been proposed as one of the possible mechanisms underlying Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). However, recent studies are beginning to connect different pieces of the same puzzle: persistent viral material in tissues, prolonged activation of virus-specific T cells, functional exhaustion, herpesvirus-related abnormalities, and genetic differences in antiviral immune surveillance.
The idea is relatively straightforward. In certain susceptible individuals, a pathogen may escape adequate immune control and maintain prolonged antigenic stimulation. Over time, this could contribute to chronic immune hyperactivation, alterations in T cell differentiation, and impaired surveillance against other persistent viruses, particularly Epstein–Barr virus (EBV).
In some patients, these processes could also promote inflammatory and autoimmune abnormalities.
We proposed several of these connections in our publications from 2021 and 2023, initially focusing on EBV and ME/CFS, and subsequently expanding the model to include SARS-CoV-2 persistence and possible secondary EBV reactivation in Long COVID.
Today, we have considerably more evidence supporting the biological plausibility of this model.
But if persistent viral activity contributes to maintaining illness in certain patients, shouldn’t we be investigating much more seriously whether interrupting that activity could improve their condition?
This is where antiviral treatments become particularly interesting.
Ruiz-Pablos et al. (2021):
doi.org/10.3389/fimmu.2021.6…
Ruiz-Pablos et al. (2023):
doi.org/10.1186/s12967-023-0…




























